Skip to main content
OpenTrials

Clinical trial condition

Hidradenitis

Explore clinical trials studying Hidradenitis. Study availability and eligibility vary by location and protocol.

186 public trials 50 recruiting studies
Refine in advanced search Browse all conditions

Hidradenitis trial results

Completed

Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT03487276

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +12 more
Locations
  • InflaRX Investigational Site Birmingham, Alabama, United States
  • InflaRX Investigational Site Fort Myers, Florida, United States
  • InflaRX Investigational Site Miami, Florida, United States
  • InflaRX Investigational Site Sandy Springs, Georgia, United States
View all 41 locations
View Trial Details
Completed

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

NCT03001115

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Kyungpook National Univ Hosp /ID# 162930 Daegu, Daegu Gwang Yeogsi, South Korea
  • Seoul National Univ Bundang ho /ID# 202254 Seongnam, Gyeonggido, South Korea
  • CHA Bundang Medical center, CHA University /ID# 203364 Seongnam-si, Gyeonggido, South Korea
  • Ajou University Hospital /ID# 163243 Suwon, Gyeonggido, South Korea
View all 19 locations
View Trial Details
Completed

Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically

NCT02808975

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Wallace Medical Group, Inc. /ID# 171289 Beverly Hills, California, United States
  • Encino Research Center / T. Jo /ID# 171347 Encino, California, United States
  • University of California Irvine /ID# 170054 Irvine, California, United States
  • Tulane Univ /ID# 168441 New Orleans, Louisiana, United States
View all 55 locations
View Trial Details
Completed

Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa

NCT02904902

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Nagoya City University Hospital /ID# 151495 Nagoya, Aichi-ken, Japan
  • Kurume University Hospital /ID# 152579 Kurume-shi, Fukuoka, Japan
  • Takagi Dermatological Clinic /ID# 151906 Obihiro, Hokkaido, Japan
  • University of the Ryukyus Hosp /ID# 152268 Nakagami-gun, Okinawa, Japan
View Trial Details
Completed

Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness

NCT02896920

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
Locations
  • Institute for Skin Advancement /ID# 152448 Calgary, Alberta, Canada
  • Alberta DermaSurgery Centre /ID# 153834 Edmonton, Alberta, Canada
  • Jason Ronald Sneath Medical Co /ID# 152462 Brandon, Manitoba, Canada
  • Winnipeg Clinic, Manitoba, CA /ID# 153830 Winnipeg, Manitoba, Canada
View all 22 locations
View Trial Details
Completed

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting

NCT02786576

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Krankenanstalt Rudolfstiftung /ID# 166804 Vienna, State of Vienna, Austria
  • LKH-Univ. Klinikum Graz /ID# 166802 Graz, Austria
  • Klinikum Wels - Grieskirchen /ID# 158017 Wels, Austria
  • UZ Brussel /ID# 154218 Jette, Brussels Capital, Belgium
View all 83 locations
View Trial Details
Completed

Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

NCT02739828

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Universitetssjukhuset Linköping Linkoping, Västra Götaland County, Sweden
  • Hallands Hospital Halmstad Halmstad, Sweden
  • Blekinge Hospital Karlskrona, Sweden
  • Skaraborgs Hospital Skövde, Sweden
View Trial Details

Related conditions